A Pipeline of Innovation for Pharmacy
Tracks
Pharmacy Assistant National Conference
| Saturday, September 2, 2023 |
| 9:45 AM - 10:15 AM |
| Maritime Ballroom 4 |
Sponsored by AFT Pharmaceuticals
Details
AFT Pharmaceuticals has a bulging pipeline of new and innovative products that will be available in Australian pharmacies for 2023, and this session will provide information on the most significant upcoming launches. Maxigesic®, the major sponsor of the PATY Award, is expanding its paracetamol + ibuprofen pain relief range with further first-to-market innovation, and there is much more on the near horizon. Globally, liposomal technology is delivering enhanced consumer benefits in natural health, and now it’s Australia’s turn to discover next generation liposomal technology to help boost immunity. Additionally, the reintroduction of slow release hydrogen peroxide cream, Crystaderm, to treat skin infections and a specially formulated pseudoephedrine soft gel cap designed to reduce its misuse potential will be discussed.
Speaker
Dr Hartley Atkinson
CEO
AFT Pharmaceuticals
A pipeline of innovation for pharmacy
Biography
Dr Hartley Atkinson is a registered pharmacist with a Masters of Pharmaceutical Chemistry with Distinction and Doctorate in Pharmacology. He has published 30 research papers, including in the world-leading New England Journal of Medicine, and two book chapters. Following roles as Medical Director and Sales and Marketing Director at Roche, Hartley and his wife, Marree, founded AFT Pharmaceuticals in 1997. In 2015, AFT Pharmaceuticals listed on the ASX and NZX, with the founders maintaining a 70% stake in the business. Today, AFT sells in excess of $157M per annum in over 60 countries around the globe, including its main market of Australia.
